Will the FDA Approve Pfizer and Acura’s Acurox? – Motley Fool

Will the FDA Approve Pfizer and Acura's Acurox? Motley Fool At the time, the duo was also adding niacin to the drug to deter abuse. Read more »

Analysts see lower sales for Abbott’s Niaspan – BusinessWeek

Analysts see lower sales for Abbott's Niaspan BusinessWeek On Thursday federal scientists halted a large study of its Niaspan drug, a prescription form of niacin , after preliminary results showed the pill failed to prevent heart attacks or strokes. Niacin is a form of vitamin B that boosts good cholesterol , ... Read more »

Impax challenges Abbott’s Simcor patent – Drug Store News

Proactive Investors USA & Canada Impax challenges Abbott's Simcor patent Drug Store News Impax said it had filed an approval application with the Food and Drug Administration for niacin and simvastatin extended-release tablets in the 1000 mg/20 ... Read more »

Abbott Labs files suit against Impax over Simcor patent challenge; Ranbaxy … – The Pharma Letter

Abbott Labs files suit against Impax over Simcor patent challenge; Ranbaxy ... The Pharma Letter ... has initiated a challenge of patents listed in connection with the cholesterol lowerer Simcor ( niacin /simvastatin) extended-release tablets, 1000/20mg. Read more »

Acura Pharma FDA Panel Preview – TheStreet.com

Acura Pharma FDA Panel Preview TheStreet.com Niacin is an active ingredient in vitamins and at high doses (Abbott Labs'(ABT) Niaspan) it can reduce cholesterol . In Acurox, niacin is there for its side ... Read more »